Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × Tamoxifen × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Central Nervous System Neoplasms 4 Gliosarcoma 3 Brain Neoplasms 3 Glioma 2 Astrocytoma 2 Oligodendroglioma 1 Neoplasms 1 Neoplasm Metastasis 1 Glioma, Subependymal 1 Ependymoma 1 Disease Progression 1

Interventions

vandetanib 2 Bevacizumab 2 Anthropogenic Effects 2 Temozolomide 1 Tamoxifen 1 Steroids 1 Irinotecan 1 Carboplatin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

43 enrolled 11 charts

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡